Health Condition 1: C642- Malignant neoplasm of left kidney,except renal pelvis Health Condition 2: C652- Malignant neoplasm of left renal pelvis Health Condition 3: C641- Malignant neoplasm of right kidney, except renal pelvis Health Condition 4: C651- Malignant neoplasm of right renalpelvis Health Condition 5: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvis Health Condition 6: C659- Malignant neoplasm of unspecifiedrenal pelvis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anesthesiologists (ASA) physical status 1- 3.
Exclusion criteria
Exclusion criteria: 1) Patients not willing to be a part of the study. 2) Patients allergic to local anaesthetic drug. 3) Patients with infection in the area of planned injection site. 4)Patients with cognitive dysfunction, dementia, preexisting communication disorders. 5) Emergency surgeries. 6) Patients currently prescribed with ongoing preoperative opioid analgesics or who had current acute pain being treated or chronic pain syndromes or those receiving medical therapies considered to result in tolerance to opioid, deranged organ system function in the form of altered coagulation profile, severe hepatic and renal dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score evaluation by numerical rating scaleTimepoint: Immediate post operative period till hospital discharge | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first rescue analgesia Total opioid consumption Quality of recovery Patient satisfactionTimepoint: Immediate post operative period till hospital discharge | — |
Countries
India
Contacts
Health Care Global Enterprises Ltd